Antibiotic use and inflammatory bowel disease: number needed to harm? Authors' reply

被引：0
|
作者：
Faye, Adam S. [1 ,2 ,4 ]
Jess, Tine [2 ,3 ]
机构：
[1] New York Univ, Dept Med & Populat Hlth, Grossman Sch Med, New York, NY USA
[2] Aalborg Univ, Ctr Mol Predict Inflammatory Bowel Dis, Dept Clin Med, Copenhagen, Denmark
[3] Aalborg Univ, Dept Gastroenterol & Hepatol, Aalborg, Denmark
[4] New York Univ, Grossman Sch Med, New York, NY 10016 USA
来源：
GUT | 2023年
关键词：
IBD; ANTIBIOTICS; CROHN'S DISEASE; ULCERATIVE COLITIS;
D O I：
10.1136/gutjnl-2023-329851
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Thiopurine metabolites and TPMT activity measurement in inflammatory bowel disease: authors' reply
    Gonzalez-Lama, Y.
    Gisbert, J. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (09) : 1139 - 1140
  • [32] ASSOCIATION BETWEEN ANTIBIOTIC USE AND INFLAMMATORY BOWEL DISEASE OUTCOMES
    Liu, Luke
    O'Charoen, Sirimon
    Fehlmann, Tara
    Roedder, Silke
    Wendt, Emily
    Billin, Andrew
    Younis, Islam
    Iqbal, Shahed
    INFLAMMATORY BOWEL DISEASES, 2023, 29 : S33 - S34
  • [33] Letter: thiopurine blood monitoring for patients with inflammatory bowel disease - authors' reply
    Chouchana, L.
    Narjoz, C.
    Beaune, P.
    Loriot, M. -A.
    Roblin, X.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (06) : 743 - 744
  • [34] Letter: off-label use of hyperbaric oxygen therapy in inflammatory bowel disease-Authors' reply
    Simsek, Melek
    de Boer, Nanne K. H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (01) : 216 - 217
  • [35] Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease-Authors' reply
    Christensen, B.
    Gibson, P. R.
    Rubin, D. T.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (10) : 1423 - 1424
  • [36] Letter: irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease - authors' reply
    Diederen, K.
    Hoekman, D. R.
    Benninga, M. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (03) : 309 - 310
  • [37] Editorial: diagnostic precision of iron deficiency in inflammatory bowel disease. Authors' reply
    Daude, Sebastien
    Gastin, Isabelle
    Peyrin-Biroulet, Laurent
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (02) : 401 - 401
  • [38] Letter: Thioguanine, an under-utilised option in inflammatory bowel disease? Authors' reply
    Vasudevan, Abhinav
    Con, Danny
    van Langenberg, Daniel R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (08) : 1011 - 1011
  • [39] 5-aminosalicylates in inflammatory bowel disease and chronic renal failure: Authors' reply
    Muller, AF
    Stevens, PE
    McIntyre, AS
    Ellison, H
    Logan, RF
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 (06) : 579 - 580
  • [40] Editorial: concurrence of coeliac disease with inflammatory bowel disease - is big data the final arbiter? Authors' reply
    Sonnenberg, Amnon
    Genta, Robert M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (10) : 1155 - 1156
12345